{"id":"W2432860777","doi":"10.1200/jco.2013.31.15_suppl.1049","title":"A phase III, open-label, randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes: Subgroup analyses.","year":2013,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Capecitabine; Eribulin; Medicine; Internal medicine; Hazard ratio; Taxane; Metastatic breast cancer; Regimen; Oncology; Chemotherapy; Chemotherapy regimen; Anthracycline; Gastroenterology; Progression-free survival; Breast cancer; Cancer; Confidence interval; Colorectal cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003273682,0.002363569,0.004408918,0.0006672248,0.0005039299,0.001370093,0.001014994,0.001626889,0.006361708],"category_scores_gemma":[0.003102894,0.0008119948,0.004134889,0.0007471819,0.000907608,0.001044163,0.0005564863,0.002997914,0.0008991165],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001359941,"about_ca_system_score_gemma":0.002000883,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001511588,"about_ca_topic_score_gemma":0.005206979,"domain_scores_codex":[0.9988269,0.0006880077,0.00009748444,0.0001490027,0.0000665081,0.000171976],"domain_scores_gemma":[0.9986375,0.0004575582,0.0003100559,0.0001233117,0.0000825594,0.0003890164],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9833553,0.003761947,0.0008927158,0.0004253068,0.002442551,0.0000448054,0.0000525029,0.0003052558,0.002288379,0.00005590387,0.0003945209,0.00598084],"study_design_scores_gemma":[0.935621,0.05890781,0.002073477,0.00003240562,0.001819571,0.000035981,0.00004246076,0.000424749,0.0003350811,0.0001664986,0.0005222646,0.00001869331],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9763414,0.006840229,0.001267923,0.0008401138,0.0007615927,0.009509642,0.002354649,0.0001233129,0.001960988],"genre_scores_gemma":[0.9809815,0.002981425,0.001584215,0.00134026,0.0004551846,0.00827656,0.001462629,0.00003002228,0.002888365],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006361708,"threshold_uncertainty_score":0.02128196,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1406021837807702,"score_gpt":0.5207636311247795,"score_spread":0.3801614473440094,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}